Cargando…
Epigenetics in blood–brain barrier disruption
The vessels of the central nervous system (CNS) have unique barrier properties. The endothelial cells (ECs) which comprise the CNS vessels contribute to the barrier via strong tight junctions, specific transporters, and limited endocytosis which combine to protect the brain from toxins and maintains...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025355/ https://www.ncbi.nlm.nih.gov/pubmed/33823899 http://dx.doi.org/10.1186/s12987-021-00250-7 |
_version_ | 1783675477593948160 |
---|---|
author | Ihezie, Stephanie A. Mathew, Iny Elizebeth McBride, Devin W. Dienel, Ari Blackburn, Spiros L. Thankamani Pandit, Peeyush Kumar |
author_facet | Ihezie, Stephanie A. Mathew, Iny Elizebeth McBride, Devin W. Dienel, Ari Blackburn, Spiros L. Thankamani Pandit, Peeyush Kumar |
author_sort | Ihezie, Stephanie A. |
collection | PubMed |
description | The vessels of the central nervous system (CNS) have unique barrier properties. The endothelial cells (ECs) which comprise the CNS vessels contribute to the barrier via strong tight junctions, specific transporters, and limited endocytosis which combine to protect the brain from toxins and maintains brain homeostasis. Blood–brain barrier (BBB) leakage is a serious secondary injury in various CNS disorders like stroke, brain tumors, and neurodegenerative disorders. Currently, there are no drugs or therapeutics available to treat specifically BBB damage after a brain injury. Growing knowledge in the field of epigenetics can enhance the understanding of gene level of the BBB and has great potential for the development of novel therapeutic strategies or targets to repair a disrupted BBB. In this brief review, we summarize the epigenetic mechanisms or regulators that have a protective or disruptive role for components of BBB, along with the promising approaches to regain the integrity of BBB. |
format | Online Article Text |
id | pubmed-8025355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80253552021-04-07 Epigenetics in blood–brain barrier disruption Ihezie, Stephanie A. Mathew, Iny Elizebeth McBride, Devin W. Dienel, Ari Blackburn, Spiros L. Thankamani Pandit, Peeyush Kumar Fluids Barriers CNS Review The vessels of the central nervous system (CNS) have unique barrier properties. The endothelial cells (ECs) which comprise the CNS vessels contribute to the barrier via strong tight junctions, specific transporters, and limited endocytosis which combine to protect the brain from toxins and maintains brain homeostasis. Blood–brain barrier (BBB) leakage is a serious secondary injury in various CNS disorders like stroke, brain tumors, and neurodegenerative disorders. Currently, there are no drugs or therapeutics available to treat specifically BBB damage after a brain injury. Growing knowledge in the field of epigenetics can enhance the understanding of gene level of the BBB and has great potential for the development of novel therapeutic strategies or targets to repair a disrupted BBB. In this brief review, we summarize the epigenetic mechanisms or regulators that have a protective or disruptive role for components of BBB, along with the promising approaches to regain the integrity of BBB. BioMed Central 2021-04-06 /pmc/articles/PMC8025355/ /pubmed/33823899 http://dx.doi.org/10.1186/s12987-021-00250-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Ihezie, Stephanie A. Mathew, Iny Elizebeth McBride, Devin W. Dienel, Ari Blackburn, Spiros L. Thankamani Pandit, Peeyush Kumar Epigenetics in blood–brain barrier disruption |
title | Epigenetics in blood–brain barrier disruption |
title_full | Epigenetics in blood–brain barrier disruption |
title_fullStr | Epigenetics in blood–brain barrier disruption |
title_full_unstemmed | Epigenetics in blood–brain barrier disruption |
title_short | Epigenetics in blood–brain barrier disruption |
title_sort | epigenetics in blood–brain barrier disruption |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025355/ https://www.ncbi.nlm.nih.gov/pubmed/33823899 http://dx.doi.org/10.1186/s12987-021-00250-7 |
work_keys_str_mv | AT iheziestephaniea epigeneticsinbloodbrainbarrierdisruption AT mathewinyelizebeth epigeneticsinbloodbrainbarrierdisruption AT mcbridedevinw epigeneticsinbloodbrainbarrierdisruption AT dienelari epigeneticsinbloodbrainbarrierdisruption AT blackburnspirosl epigeneticsinbloodbrainbarrierdisruption AT thankamanipanditpeeyushkumar epigeneticsinbloodbrainbarrierdisruption |